AMR surveillance tracks changes in microbial populations, permits the early detection of resistant strains of public health importance, and supports the prompt notification and investigation of outbreaks.

Surveillance findings are needed to inform clinical therapy decisions, to guide policy recommendations, and to assess the impact of resistance containment interventions.

Resources are shared here on global AMR surveillance systems strengthening across human health, animal health and agricultural sectors.
 

WHO: Global Antimicrobial Resistance Surveillance System (GLASS)
The Global Antimicrobial Resistance Surveillance System (GLASS) has been developed to facilitate and encourage a standardized approach to AMR surveillance globally and in turn support the implementation of the Global action plan on antimicrobial resistance.

The Global Antimicrobial Resistance Surveillance System Manual for Early Implementation addresses the early phase of implementation of GLASS, focussing on surveillance of resistance in common human bacterial pathogens. The intended readership of this publication is public health professionals and health authorities responsible for national AMR surveillance. It outlines the GLASS standards and describes the road map for implementation of the system between 2015 and 2019. Further development of GLASS will be based on the lessons learnt during this period. The GLASS report 2020, which includes data from 66 countries, is available HERE

WHO: Surveillance standards for antimicrobial resistance
The purpose of this manual is to provide national agencies with a framework within which existing surveillance of communicable disease and infection can be reviewed in order to determine the priorities for epidemiological surveillance of diseases caused by microorganisms exhibiting antimicrobial resistance. The manner of implementation of antimicrobial resistance surveillance most appropriate in a particular country will be determined by a number of factors, including the range of diseases of public health significance, the organization of healthcare services and the resources available.

FIND - AMR Cx: Connectivity for AMR surveillance
This project aims to demonstrate how innovative digital tools can be used to improve and increase the data available for AMR surveillance. By enabling a complete information loop, this project allows AMR data from local sources, such as diagnostics in clinics and laboratories, to be linked to national level surveillance systems.

BD Tool: Calculate the estimated clinical and economic impact of antimicrobial resistance
Infections caused by resistant organisms are associated with high mortality rates and costs compared to those susceptible to antimicrobial therapy. Delays in appropriate diagnosis and treatment increase the chances of a negative clinical outcome for patients with these infections. This calculator quantifies the estimated clinical and economic impact of antimicrobial resistance.

SEDRIC: Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings
The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) is a think tank designed to bring together a range of international experts to share expertise and take action to tackle the gaps in drug-resistant infection surveillance and epidemiology. This paper explores how untapped sources of data could provide a short-term solution that bridges the gap between now and the time when routine surveillance capacity will have been established and how this could continue to support surveillance efforts in the future. SEDRIC also maps global AMR surveillance projects

If you are working in AMR surveillance you can join their global network of experts

ATLAS, Antimicrobial Testing Leadership and Surveillance
ATLAS includes a fully-searchable database of surveillance data. Users may process data from one or more surveillance programmes to produce reports, tables and geographic heatmaps of antibacterial or antifungal resistance over time.

Africa CDC: Anti-Microbial Resistance Surveillance Network AMRSNET
In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis, gonorrhea, and dysentery. Recognizing the urgent need for action, the World Health Assembly adopted the Global Action Plan on Antimicrobial Resistance in May 2015. In accordance with the Global Action Plan and to meet needs specific to Africa, Africa CDC have established the Anti-Microbial Resistance Surveillance Network (AMRSNET). AMRSNET is a network of public health institutions and leaders from human and animal health sectors who will collaborate to measure, prevent, and mitigate harms from AMR organisms.

University of Oxford TropMed webinars: AMR Surveillance
In these webinars from the University of Oxford Centre for Tropical Medicine and Global Health TropMed series, clinical microbiologists from the Centre's oversees units discussed antimicrobial resistance surveillance. Prof Paul Turner (COMRU) discusses the pressing need for quality laboratory data in low and middle-income countries, for better antimicrobial resistance surveillance. Prof H Rogier van Doorn (OUCRU) discusses AMR surveillance data, from antibiotic susceptibility testing results to treatment regimen. 

GLASS guide for national surveillance systems for monitoring antimicrobial consumption in hospitals
This is a guide for national surveillance systems for monitoring antimicrobial consumption in hospitals. It aims to help countries establish mechanisms enabling routine monitoring of antimicrobial consumption, particularly in low-resource settings, that can generate data to help build a greater understanding of how antimicrobials are being used and consumed in national, regional, and local hospitals.

Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): general protocol
This is a general protocol document for the development and pilot testing of the Enhanced Gonorrhoea Surveillance Programme (EGASP). It describes the objectives and the methods of EGASP surveillance and guidance on how to implement and monitor EGASP.

Antimicrobial resistance surveillance in Europe 2022 – 2020 data (2022)
This is a jointly published report by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe on Antimicrobial resistance surveillance in Europe. The report pinpoints the widespread of AMR in the region and what the ECDC and WHO are doing to curtail it.

Sequencing for antimicrobial resistance surveillance
Sequencing for antimicrobial resistance surveillance is a report by FIND which highlights the importance of genomic sequencing in AMR surveillance; provides examples of next-generation sequencing technologies, workflows, and databases; and discusses the potential of culture-free sequencing.